Key facts
- PreemptiveAI’s last known valuation is $13.7M (Jan 2022).
- It has raised $6.3M; the latest was Early Stage VC in Apr 2026.
- Notable investors include Evolution VC Partners, Precursor Ventures, Sand Hill Angels, Good Friends, Inspired Capital (New York) — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for PreemptiveAI
- ·The full record, as it builds
Funding rounds
No funding rounds for PreemptiveAI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PreemptiveAI
Developer of a healthcare technology platform designed for real-time health outcome prediction using biomedical signals from smartphones and wearable devices. The company's platform utilizes advanced signal processing and machine learning to interpret physiological patterns, supporting early diagnosis, customized treatments, and proactive patient involvement, enabling the healthcare industry to refine medical services, allocate resources efficiently, and create targeted therapies, ultimately improving clinical results and reducing expenditures.
- Sector
- Healthcare
- HQ
- Seattle, WA, United States
- Founded
- 2022
- Employees
- 16
- Website
- preemptive.health/
- Ownership
- Privately Held (backing)
PreemptiveAI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PreemptiveAI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PreemptiveAI in its N-PORT filings yet. We sweep new filings monthly.